semaglutide zepbound Medicare GLP-1 Coverage for Weight Loss Starts July 2026: What You Need to Know Semaglutide GLP-1 Vs Zepbound For

Your provider can resubmit with additional clinical evidence or request expedited review

There is no blood test that measures GLP-1 receptor sensitivity, so you cannot track this process directly

If you're thinking about stopping, that's a conversation to have with your clinician about tapering strategy and maintenance planning - not a unilateral decision to make on your own

Ozempic is contraindicated if you have a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Lixisenatide has also been shown to prevent the free fatty acid-induced reduction of eNOS phosphorylation in endothelial cells (Zhao et al., 2019)

Theyre still used for blood sugar management in people with type 2 diabetes, to great effect a recent survey reported that 25 percent of US adults with a diabetes diagnosis were using a GLP-1RA in 2024, often in combination with insulin or other treatments